PL404138A1 - Benzoic acid derivatives as IL-15Rα receptor inhibitors - Google Patents
Benzoic acid derivatives as IL-15Rα receptor inhibitorsInfo
- Publication number
- PL404138A1 PL404138A1 PL404138A PL40413813A PL404138A1 PL 404138 A1 PL404138 A1 PL 404138A1 PL 404138 A PL404138 A PL 404138A PL 40413813 A PL40413813 A PL 40413813A PL 404138 A1 PL404138 A1 PL 404138A1
- Authority
- PL
- Poland
- Prior art keywords
- benzoic acid
- acid derivatives
- receptor inhibitors
- overproduction
- tautomers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Wynalazek dotyczy zastosowania pchodnych kwasu benzoesowego o wzorze (I), ich tautomerów, izomerów, farmaceutycznie dopuszczalnych soli i solwatów, do zapobiegania i leczenia chorób, u podłoża których leży nadprodukcja interleukiny 15.The invention relates to the use of the benzoic acid derivatives of formula (I), their tautomers, isomers, pharmaceutically acceptable salts and solvates, for the prevention and treatment of diseases which are the cause of overproduction of interleukin.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL404138A PL404138A1 (en) | 2013-05-31 | 2013-05-31 | Benzoic acid derivatives as IL-15Rα receptor inhibitors |
PCT/IB2014/000894 WO2014191822A1 (en) | 2013-05-31 | 2014-05-29 | BENZOIC ACID DERIVATIVES AS IL-15Rα RECEPTOR INHIBITORS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL404138A PL404138A1 (en) | 2013-05-31 | 2013-05-31 | Benzoic acid derivatives as IL-15Rα receptor inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL404138A1 true PL404138A1 (en) | 2014-12-08 |
Family
ID=51257533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL404138A PL404138A1 (en) | 2013-05-31 | 2013-05-31 | Benzoic acid derivatives as IL-15Rα receptor inhibitors |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL404138A1 (en) |
WO (1) | WO2014191822A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3366683A1 (en) * | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Cyclic amides, acteamides and ureas useful as potassium channel openers |
US11278505B2 (en) | 2017-04-24 | 2022-03-22 | University Of Massachusetts | Diagnosis and treatment of vitiligo |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4436127A1 (en) * | 1994-09-27 | 1996-03-28 | Deutsches Rheumaforschungszent | Use of benzoic or pyridine:carboxylic acid or amide cpds. |
US6924308B1 (en) * | 1997-07-30 | 2005-08-02 | Howard L. Elford | Therapeutic process for inhibiting NF-κB |
US20120178697A9 (en) * | 2003-09-22 | 2012-07-12 | Jie Zheng | Compositions and methods for the inhibition of dishevelled proteins |
CU23472A1 (en) | 2004-09-17 | 2009-12-17 | Ct Ingenieria Genetica Biotech | ANTAGONIST PEPTIDE OF INTERLEUCINE-15 |
DE102005005399A1 (en) * | 2005-02-05 | 2006-08-10 | Lts Lohmann Therapie-Systeme Ag | Use of 2,4-dihydroxy-3-methylbenzoate derivatives for preparing medicaments or as basic substance for the development of other agents used for treating benign prostate hyperplasia, prostate carcinoma or spinobulbar muscular atrophy |
CN100427082C (en) * | 2005-08-02 | 2008-10-22 | 盛华(广州)医药科技有限公司 | Application of hydroxybenzoate acid and its analogue in the preparing process of medicine for preventing and treating virus infection |
US20080114063A1 (en) * | 2006-08-16 | 2008-05-15 | Action Medicines | Use of 2,5-Dihydroxybenzene Derivatives for the Treatment of Tissue Reactive Diseases |
US7867989B2 (en) * | 2007-06-22 | 2011-01-11 | Vinitha Moolchand Thadani | α-glucosidase inhibitors from lichens |
US20110257177A1 (en) * | 2008-09-22 | 2011-10-20 | Calcimedica, Inc. | Benzylthiotetrazole inhibitors of store operated calcium release |
CU23716A1 (en) | 2008-09-30 | 2011-10-05 | Ct Ingenieria Genetica Biotech | ANTAGONIST PEPTIDE OF THE ACTIVITY OF INTERLEUCINA-15 |
WO2011006158A2 (en) * | 2009-07-10 | 2011-01-13 | University Of Maryland, Baltimore | Targeting nad biosynthesis in bacterial pathogens |
-
2013
- 2013-05-31 PL PL404138A patent/PL404138A1/en unknown
-
2014
- 2014-05-29 WO PCT/IB2014/000894 patent/WO2014191822A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014191822A1 (en) | 2014-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
PH12018502125A1 (en) | Bipyrazole derivatives as jak inhibitors | |
PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
PH12018500040A1 (en) | Indazole and azaindazole compounds as irak-4 inhibitors | |
EA201691803A1 (en) | HUMAN PLASMA KALLIKREIN INHIBITORS | |
MD20160106A2 (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as IRAK4 inhibitors | |
EA201590224A1 (en) | IMIDAZOTRIASINCARBONITRILE USED AS KINASE INHIBITORS | |
EA201692249A1 (en) | PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | |
EA201591360A1 (en) | AZABENZIMADAZLES AS INHIBITORS INHIBITORS PDE4 FOR THE TREATMENT OF THE CNS AND OTHER DISORDERS | |
UA113160C2 (en) | IL17 AND IFN-GAMMA INHIBITION FOR TREATMENT OF AUTOIMMUNE INFLAMMATION | |
UA110048C2 (en) | IL17 INHIBITION AND IFN-GAMMA FOR TREATMENT OF AUTOIMMUNE INFLAMMATION | |
EA201692265A1 (en) | PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | |
MX2017007607A (en) | Inhibitors of cellular necrosis and related methods. | |
NI201500115A (en) | ESTRA-1,3,5 (10), 16-TETRAENE-3-CARBOXAMIDES FOR THE INHIBITION OF 17B-HYDROXIESTEROID DEHYDROGENASE (AKR1 C3) | |
EA029499B9 (en) | Rorc2 inhibitors and methods of use thereof | |
MX2018005004A (en) | Substituted indazole compounds as rorgammat inhibitors and uses thereof. | |
EA201790830A1 (en) | ALDOSTERONSYNTASE INHIBITORS | |
EA201790253A1 (en) | ALDOSTERONSYNTASE INHIBITORS | |
MX2017013099A (en) | Methods for the treatment of inflammatory disorders. | |
EA201791480A1 (en) | NEW BENZIMIDAZOLE DERIVATIVES AS ANTIHARMONAL AGENTS | |
EA201990313A1 (en) | DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR | |
EA201500737A1 (en) | PYRAZOLILKARBOXAMIDA II AS CRAC CHANNEL INHIBITORS | |
EA201500736A1 (en) | PYRAZOLILKARBOXAMIDA I AS CRAC CHANNEL INHIBITORS | |
PL404138A1 (en) | Benzoic acid derivatives as IL-15Rα receptor inhibitors | |
NZ738247A (en) | 4-(3-pyrazolylamino)-benzimidazole compounds and their use as jak1 inhibitors |